Published in Cancer on August 15, 2001
Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med (2003) 3.11
Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol (2010) 2.45
Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer (2008) 2.23
Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol (2002) 2.09
Limits of observational data in determining outcomes from cancer therapy. Cancer (2008) 1.97
Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc (2004) 1.93
Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer (2007) 1.80
External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med Care (2006) 1.74
Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women. J Gerontol A Biol Sci Med Sci (2005) 1.73
Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. J Clin Oncol (2014) 1.62
The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol (2008) 1.28
Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. J Clin Epidemiol (2005) 1.27
Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer (2005) 1.07
Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancer. Support Care Cancer (2010) 1.03
Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer (2009) 1.00
Area-level poverty is associated with greater risk of ambulatory-care-sensitive hospitalizations in older breast cancer survivors. J Am Geriatr Soc (2008) 0.89
Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort. J Clin Oncol (2005) 0.87
Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. Breast J (2004) 0.86
Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer. Med Oncol (2008) 0.84
A literature review to investigate the link between psychosocial characteristics and treatment adherence in cancer patients. Oncol Rev (2012) 0.81
Socioeconomic status and chemotherapy use for melanoma in older people. Can J Aging (2011) 0.80
Factors affecting receipt of chemotherapy in women with breast cancer. Int J Womens Health (2010) 0.79
Development of a Risk Prediction Model to Individualize Risk Factors for Surgical Site Infection After Mastectomy. Ann Surg Oncol (2016) 0.78
Adjuvant chemotherapy and survival of elderly korean patients with breast carcinoma. J Breast Cancer (2012) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol (1993) 13.16
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet (1998) 12.78
Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care (1993) 9.72
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group. N Engl J Med (1988) 4.68
NIH consensus conference. Treatment of early-stage breast cancer. JAMA (1991) 4.35
Treatment of breast cancer. N Engl J Med (1998) 4.32
Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Med Care (2000) 2.36
Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol (2001) 2.17
Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol (1989) 1.91
Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care (2000) 1.90
Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol (1999) 1.86
The effect of age on the care of women with breast cancer in community hospitals. J Gerontol (1987) 1.65
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
Adjuvant therapy for breast cancer. NIH Consens Statement (2001) 1.51
Consensus conference. Adjuvant chemotherapy for breast cancer. JAMA (1985) 1.40
Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat (1996) 1.27
The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines? Cancer (1998) 1.24
Patterns of breast cancer care in the elderly. Cancer (1996) 1.13
Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer. CA Cancer J Clin (1999) 1.12
1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg (1994) 1.09
Taxol in the management of cancers of the breast and the ovary. Cancer Invest (2000) 1.00
Breast cancer in the elderly. Current patterns of care. J Am Geriatr Soc (1986) 0.94
Results of the 1983 patterns of care process survey for definitive breast irradiation. Int J Radiat Oncol Biol Phys (1991) 0.92
The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women. Cancer (1994) 0.91
Patterns of treatment for older women with newly diagnosed breast carcinoma. Am J Clin Oncol (1999) 0.81
Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med (1977) 4.59
Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med (1992) 4.30
Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med (1977) 3.38
Emotional well-being predicts subsequent functional independence and survival. J Am Geriatr Soc (2000) 3.34
Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol (1980) 3.21
Regulation of the immune response by prostaglandins. J Clin Immunol (1983) 3.12
Choice of cancer therapy varies with age of patient. JAMA (1986) 2.58
The association between emotional well-being and the incidence of stroke in older adults. Psychosom Med (2001) 2.57
Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. JAMA (1998) 2.44
A piece of my mind. Chaos, and the limits of modern medicine. JAMA (1997) 2.20
Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol (2001) 2.17
Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation. J Clin Invest (1978) 2.13
Neighbourhood composition and depressive symptoms among older Mexican Americans. J Epidemiol Community Health (2003) 2.10
Lower body functioning as a predictor of subsequent disability among older Mexican Americans. J Gerontol A Biol Sci Med Sci (1998) 1.96
Patient characteristics that influence physician behavior. Med Care (1982) 1.95
Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc (1992) 1.92
Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care (2000) 1.90
Physician behaviors that correlate with patient satisfaction. J Med Educ (1982) 1.89
Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol (1999) 1.86
An approach to identifying incident breast cancer cases using Medicare claims data. J Clin Epidemiol (2000) 1.83
Knowledge and use of placebos by house officers and nurses. Ann Intern Med (1979) 1.66
Suppressor cell function in sarcoidosis. Ann Intern Med (1979) 1.65
Relationship between low blood pressure and depressive symptomatology in older people. J Am Geriatr Soc (2000) 1.62
Spontaneous fractures of the long bones in nursing home patients. Am J Med (1991) 1.55
The effect of medical conditions on the functional limitations of Mexican-American elderly. Ann Epidemiol (1996) 1.53
Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA (1983) 1.45
The utilization of fecal occult blood testing in the institutionalized elderly. J Am Geriatr Soc (1991) 1.41
Variation among cardiologists in the utilization of right heart catheterization at time of coronary angiography. Cathet Cardiovasc Diagn (1996) 1.40
A piece of my mind. Mercy killing: mercy for whom? JAMA (1991) 1.39
The relationship between blood pressure and mortality in the oldest old. J Am Geriatr Soc (2001) 1.39
Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans. J Natl Cancer Inst (1988) 1.36
Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr (1982) 1.35
Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit. J Immunol (1985) 1.30
Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA (1987) 1.28
Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination. J Gerontol (1993) 1.26
Minimal increase in use of breast-conserving surgery from 1986 to 1990. Med Care (1996) 1.26
Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol (1990) 1.25
Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc (1986) 1.25
Alcohol intake in the healthy elderly. Changes with age in a cross-sectional and longitudinal study. J Am Geriatr Soc (1990) 1.24
Disability in older adults. 2: Physical activity as prevention. Behav Med (1999) 1.24
Impact of pain on disability among older Mexican Americans. J Gerontol A Biol Sci Med Sci (2001) 1.24
The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med (1996) 1.24
Nutritional status in a healthy elderly population: vitamin C. Am J Clin Nutr (1982) 1.21
Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest (1982) 1.19
Immunological responses of healthy elderly population. Clin Exp Immunol (1982) 1.18
Hearing and cognition in the elderly. New findings and a review of the literature. Arch Intern Med (1991) 1.16
Survival of American Indian and Hispanic cancer patients in New Mexico and Arizona, 1969-82. J Natl Cancer Inst (1987) 1.16
Alcohol intake in a healthy elderly population. Am J Public Health (1987) 1.14
The use of herbal medicine by older Mexican Americans. J Gerontol A Biol Sci Med Sci (2001) 1.14
Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum (1982) 1.14
Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70. J Clin Invest (1979) 1.13
Obesity and health conditions in elderly Mexican Americans: the Hispanic EPESE. Established Population for Epidemiologic Studies of the Elderly. Ethn Dis (2000) 1.12
Spectroscopic evidence for amyloid-like interfacial self-assembly of hydrophobin Sc3. Biochem Biophys Res Commun (2001) 1.12
Effect of social support on stress-related changes in cholesterol level, uric acid level, and immune function in an elderly sample. Am J Psychiatry (1985) 1.11
Pregnancy, a temporary fetal graft of suppressor cells in autoimmune disease? Am J Med (1980) 1.10
Effect of indomethacin in vivo on humoral and cellular immunity in humans. Infect Immun (1978) 1.10
Cellular immunity in Q fever: specific lymphocyte unresponsiveness in Q fever endocarditis. J Infect Dis (1985) 1.10
Regulation of immunoglobulin production in pokeweed mitogen-stimulated cultures of lymphocytes from young and old adults. J Immunol (1982) 1.07
Changing treatment of breast cancer in New Mexico from 1969 through 1985. JAMA (1988) 1.07
Psychiatric symptoms in disliked medical patients. JAMA (1979) 1.04
Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4. J Clin Invest (1986) 1.03
The tomato effect. Rejection of highly efficacious therapies. JAMA (1984) 1.03
Perceived health change in the aftermath of a petrochemical accident: an examination of pre-accident, within-accident, and post-accident variables. J Epidemiol Community Health (2008) 1.02
High-affinity binding sites for prostaglandin E on human lymphocytes. Cell Immunol (1979) 1.01
Environmental hazards and stress: evidence from the Texas City Stress and Health Study. J Epidemiol Community Health (2009) 1.01
Role of prostaglandin in the depressed cell-mediated immune response in rheumatoid arthritis. Clin Immunol Immunopathol (1980) 1.01
Nutritional status in a healthy elderly population: dietary and supplemental intakes. Am J Clin Nutr (1982) 1.00
The association between chronic diseases and depressive symptomatology in older Mexican Americans. J Gerontol A Biol Sci Med Sci (1998) 1.00
Hearing acuity in a healthy elderly population: effects on emotional, cognitive, and social status. J Gerontol (1983) 0.99
Comparison of admission and discharge medications in two geriatric populations. J Am Geriatr Soc (1985) 0.99
Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J Immunol (1985) 0.99
Relationship between zinc intake, physical activity, and blood levels of high-density lipoprotein cholesterol in a healthy elderly population. Metabolism (1985) 0.97
Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes. J Exp Med (1979) 0.96
The presence of Ia antigen on human peripheral blood T cells and T-cell subsets: analysis with monoclonal antibodies and the fluorescence-activated cell sorter. Cell Immunol (1981) 0.96
Relationship between megadose vitamin supplementation and immunological function in a healthy elderly population. Clin Exp Immunol (1983) 0.96
Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J Clin Lab Immunol (1978) 0.96
Folate and vitamin B12 status in a healthy elderly population. J Am Geriatr Soc (1984) 0.95
Wisconsin Card Sort Test performance in a healthy elderly population. J Gerontol (1987) 0.95
Immunodeficiency of aging. Drugs Aging (1997) 0.95
Studies on the cyclic AMP response to prostaglandin in human lymphocytes. Cell Immunol (1981) 0.94
Failure to recognize efficacious treatments: a history of salicylate therapy in rheumatoid arthritis. Perspect Biol Med (1981) 0.94
Factors influencing unawareness of hypertension among older Mexican Americans. Prev Med (1997) 0.94
Undertreatment of hypertension in older Mexican Americans. J Am Geriatr Soc (1998) 0.94
Clinical significance of falling blood pressure among older adults. J Clin Epidemiol (2001) 0.93
Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease. J Clin Immunol (1987) 0.93
Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995. J Gerontol A Biol Sci Med Sci (1999) 0.93
Complications of acute myocardial infarction in patients > or = 90 years of age. Am J Cardiol (1998) 0.93
Modulation of conconavalin-A-induced suppressor cell activation by prostaglandin E2. Cell Immunol (1980) 0.92
IgM, IgA and IgG rheumatoid factors in patients with rheumatoid arthritis and normal donors. Clin Rheumatol (1985) 0.91
Inhibitors of T-cell mitogenesis: effect of mitogen dose. Cell Immunol (1979) 0.91
Ia antigen on the surface of a subfraction of T cells that bear Fc receptors for IgG. J Immunol (1980) 0.91
Non-steroidal anti-inflammatory agent inhibit the synthesis of IgM rheumatoid factor in vitro. Lancet (1982) 0.91
Anti-Ia antibody in the sera of normal subjects after in vivo antigenic stimulation. J Exp Med (1982) 0.90
Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity. Cell Immunol (1982) 0.90
Incontinentia pigmenti. Evidence for both neutrophil and lymphocyte dysfunction. Arch Dermatol (1978) 0.89
Decreased sensitivity to prostaglandin and histamine in lymphocytes from normal HLA-B12 individuals: a possible role in autoimmunity. J Immunol (1980) 0.89
Antibodies in the sera of patients with systemic lupus erythematosus that block the binding of monoclonal anti-Ia to Ia-positive targets also inhibit the autologous mixed lymphocyte response. J Immunol (1982) 0.89
Impact of selected medical conditions on self-reported lower-extremity function in Mexican-American elderly. Ethn Dis (1998) 0.89
Breast cancer care in old age: what we know, don't know, and do. J Natl Cancer Inst (1993) 0.88